There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tenaya Therapeutics (TNYA – Research Report) and Sera Prognostics (SERA – Research Report) with bullish sentiments.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TNYA:
- Tenaya Therapeutics’ Financial Tightrope: Balancing Development Costs with Cash Reserves
- Tenaya Therapeutics reports Q4 EPS (40c), consensus (44c)
- Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
- Tenaya announces publication of TN-401 gene therapy preclinical data
